Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (91-100 of 752) with videos related to

Pageof 76
Sort By:
European Heart Journal. Acute Cardiovascular Care|February 26, 2022
Basic mechanisms in cardiogenic shock: part 2 - biomarkers and treatment optionsKonstantin A Krychtiuk, Christiaan Vrints, Johann Wojta, et al.
European Heart Journal. Acute Cardiovascular Care|February 26, 2022
Basic mechanisms in cardiogenic shock: part 1-definition and pathophysiologyKonstantin A Krychtiuk, Christiaan Vrints, Johann Wojta, et al.
British Journal of Pharmacology|January 12, 2002
HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statinsFranz Wiesbauer, Christoph Kaun, Gerlinde Zorn, et al.
Current Opinion in Infectious Diseases|March 8, 2011
Inflammation and cardiac outcomePhilipp J Hohensinner, Alexander Niessner, Kurt Huber, et al.
Thrombosis and Haemostasis|October 19, 2013
Stroke and recurrent left atrial appendage thrombus in a patient with atrial fibrillation under old and new oral anticoagulants: a case reportMiklos Rohla, Matthias K Freynhofer, Herbert Hammerl, et al.
European Heart Journal. Acute Cardiovascular Care|April 8, 2024
Study Group on Cardiogenic Shock and Cardiac Arrest-a global network to improve the quality of careGuido Tavazzi, Steffen Desch, Kurt Huber, et al.
Thrombosis and Haemostasis|April 12, 2011
Genetic variability in response to clopidogrel therapy and its clinical implicationsLiana Yukhanyan, Matthias K Freynhofer, Jolanta Siller-Matula, et al.
Leukemia & Lymphoma|March 23, 2002
Idiopathic eosinophilic endomyocarditis in the absence of peripheral eosinophiliaUte Priglinger, Johannes Drach, Robert Ullrich, et al.
Thrombosis and Haemostasis|April 15, 2011
Platelet function variability and non-genetic causesIoannis Tentzeris, Jolanta Siller-Matula, Serdar Farhan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2003
Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expressionSabine Steiner, Daniela Seidinger, Kurt Huber, et al.
Pageof 76

Showing results (91-100 of 752) with videos related to

Sort By:
Pageof 76
European Heart Journal. Acute Cardiovascular Care|February 26, 2022
Basic mechanisms in cardiogenic shock: part 2 - biomarkers and treatment optionsKonstantin A Krychtiuk, Christiaan Vrints, Johann Wojta, et al.
European Heart Journal. Acute Cardiovascular Care|February 26, 2022
Basic mechanisms in cardiogenic shock: part 1-definition and pathophysiologyKonstantin A Krychtiuk, Christiaan Vrints, Johann Wojta, et al.
British Journal of Pharmacology|January 12, 2002
HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statinsFranz Wiesbauer, Christoph Kaun, Gerlinde Zorn, et al.
Current Opinion in Infectious Diseases|March 8, 2011
Inflammation and cardiac outcomePhilipp J Hohensinner, Alexander Niessner, Kurt Huber, et al.
Thrombosis and Haemostasis|October 19, 2013
Stroke and recurrent left atrial appendage thrombus in a patient with atrial fibrillation under old and new oral anticoagulants: a case reportMiklos Rohla, Matthias K Freynhofer, Herbert Hammerl, et al.
European Heart Journal. Acute Cardiovascular Care|April 8, 2024
Study Group on Cardiogenic Shock and Cardiac Arrest-a global network to improve the quality of careGuido Tavazzi, Steffen Desch, Kurt Huber, et al.
Thrombosis and Haemostasis|April 12, 2011
Genetic variability in response to clopidogrel therapy and its clinical implicationsLiana Yukhanyan, Matthias K Freynhofer, Jolanta Siller-Matula, et al.
Leukemia & Lymphoma|March 23, 2002
Idiopathic eosinophilic endomyocarditis in the absence of peripheral eosinophiliaUte Priglinger, Johannes Drach, Robert Ullrich, et al.
Thrombosis and Haemostasis|April 15, 2011
Platelet function variability and non-genetic causesIoannis Tentzeris, Jolanta Siller-Matula, Serdar Farhan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2003
Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expressionSabine Steiner, Daniela Seidinger, Kurt Huber, et al.
Pageof 76